Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project
Dennis D. Weisenburger(University of Nebraska Medical Center), Kerry J. Savage(Spinal Cord Injury BC), Nancy L. Harris(World Resources Institute), Elı́as Campo(Hospital Clínic de Barcelona), Randy D. Gascoyne(BC Cancer Agency), Massimo Federico(University of Modena and Reggio Emilia), Kensei Tobinai(National Cancer Center), Stefano Pileri(European Institute of Oncology), Jamés O. Armitage(University of Nebraska Medical Center), Julie M. Vose(University of Nebraska Medical Center), Harald Holte(Oslo University Hospital), Elaine S. Jaffe(National Cancer Institute), Françoise Berger(Hôpital Lyon Sud), Kenneth MacLennan(St James's University Hospital), Thomas Rüdiger(University of Würzburg), Won-Seog Kim(Samsung Medical Center), Bharat N. Nathwani(City Of Hope National Medical Center), Wing Y. Au(Queen Mary Hospital), Bertrand Coiffier(Unknown), Shigeo Nakamura(University of the Ryukyus)
Cited by 431
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|9.9k
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
|New England Journal of Medicine|2014|5.3k
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
|Blood|2009|4.4k
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k